Developments in Cardiovascular Proteomics

Melissa A Noronha¹, Christopher Linden² and Parveen Sharma^2*

¹Children’s Hospital of Michigan, 3901 Beaubien St. Detroit, Michigan 48201, USA

²MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, L69 3GE, UK

^*Corresponding Author: Parveen Sharma, Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Sherrington Building, Liverpool, L69 3GE, UK, Tel: 0151 7950149